Abbott stock price forecast: bearish momentum dominates as ABT risks retest of 52-week low

Abbott stock price forecast: bearish momentum dominates as ABT risks retest of 52-week low
Abbott rises 0.52% to $105.37 today

Abbott landed the number four spot on Fortune Magazine's list of America's Most Innovative Companies, the company said. Abbott shared the news on its official social media account.

Abbott stated that it has maintained a dedication to helping people live healthier, fuller lives over its 138-year history. The company said it looked different in 1888 but emphasized that this commitment has not changed.

Highlights

  • Abbott shares are under sustained bearish pressure, consistently trading below key moving average resistance areas across timeframes.
  • Momentum and trend indicators signal a weak downtrend with oversold conditions, reflecting strong seller dominance and limited rebound odds.
  • Price is expected to remain range-bound between $104.50 and $109.80, with elevated downside risk toward the 52-week low if selling persists.

Abbott (ABT) is trading at $105.37, which puts it well below the MA-20 ($109.97), MA-50 ($111.85), and MA-200 ($125.24), signaling persistent downside pressure across short-, medium-, and long-term periods. The Ichimoku Kijun sits at $109.60, making this level an immediate resistance. Near-term support rests at the MA-5 cluster ($105.30/105.50), while key support is seen around the MA-100 ($118.94); resistance is provided first by the Ichimoku Kijun ($109.60) and key resistance stands at the MA-50 ($111.85).

Momentum indicators paint a bearish picture, with MACD and ADX on D1 both pointing to weak downward momentum. RSI (34.42), Stoch RSI (19.29), and CCI (–126.03) all flag oversold conditions, suggesting the stock is under pressure but potentially stretched to the downside. BBP is deeply negative (–1.82), highlighting strong seller dominance intraday. The Awesome Oscillator also supports the prevailing downtrend. ABT is trading at $105.37, just below last week's close of $105.56, resulting in a negligible decline of 0.17%. Price now sits in the middle of this week's range, and weekly volatility stands at 5.35%. The tone for the week has been one of consolidation after touching both the high ($107.89) and low ($102.41) of the range.

Looking ahead, the expected trading range for the coming week is $104.50–$109.80, slightly above the 52-week low of $102.41 and still well below the 52-week high of $139.06. The probability of a price decrease is very high (more than 80%), while a sustained rebound is less likely given that all key W1 trend indicators (MA-50, RSI, MACD) remain bearish. In the baseline scenario, ABT will likely remain trapped in a sideways corridor. A bullish scenario could see the price push above $109.60–$111.85 if short-covering accelerates, while a bearish scenario risks a test of support at $104.50 and potentially a move toward the year’s low if seller pressure intensifies. The overall technical setup warns that further downside is more likely in the short term barring an unexpected shift in momentum.

Previously it was reported that Abbott earned a top ranking for innovation on Fortune Magazine's list of America's Most Innovative Companies. Investors should monitor the stock for any momentum driven by its reputation for innovation, as this could influence its trading dynamics in the sessions ahead.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.